LB Pharmaceuticals Inc
LBRX
$23.91
$0.331.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | 30.12% | 0.00% | 48.80% | ||
| Total Depreciation and Amortization | 4.52% | 0.00% | 66.67% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 26.75% | 0.00% | -151.38% | ||
| Change in Net Operating Assets | 95.18% | 0.00% | -201.91% | ||
| Cash from Operations | 50.87% | 0.00% | -39.68% | ||
| Capital Expenditure | 100.00% | 0.00% | -980.49% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -1,893.08% | 0.00% | 323.23% | ||
| Cash from Investing | -1,897.39% | 0.00% | 319.31% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | 566.67% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -- | -- | 566.67% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 5,945.20% | 0.00% | 177.15% | ||